Translate Bio, Inc.
(NASDAQ : TBIO)

( )
TBIO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-0.69%85.901.3%$1342.96m
AMGNAmgen Inc.
-0.21%201.561.2%$603.80m
GILDGilead Sciences, Inc.
0.72%68.740.9%$538.95m
LOXOLoxo Oncology Inc
-0.03%233.7012.7%$517.58m
BIIBBiogen Inc.
-0.51%337.221.3%$412.55m
VRTXVertex Pharmaceuticals Incorporated
-2.06%189.891.9%$326.56m
ILMNIllumina, Inc.
-0.44%302.293.5%$303.21m
REGNRegeneron Pharmaceuticals, Inc.
-0.88%401.212.6%$300.94m
ALXNAlexion Pharmaceuticals, Inc.
0.92%118.082.0%$225.36m
EXASExact Sciences Corporation
4.79%79.7125.3%$149.33m
AAgilent Technologies, Inc.
0.45%71.641.5%$147.28m
INCYIncyte Corporation
-2.75%75.202.5%$143.98m
SRPTSarepta Therapeutics, Inc.
-1.30%118.7215.4%$129.31m
LGNDLigand Pharmaceuticals Incorporated
-1.00%111.7823.1%$119.93m
NBIXNeurocrine Biosciences, Inc.
-2.15%89.325.1%$95.56m

Company Profile

Translate Bio, Inc. engages in the research and development of therapeutic drugs. Its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases. The company was founded in 2011 and is headquartered in Cambridge, MA.